Freeze Your Communication Costs
12/08/2009 – 7:00 am PST | No Comment

Most families these days feel like they can barely make ends meet, never mind have anything left in their wallet to invest.  The first step toward financial freedom is cutting expenses below your income.  In …

Read the full story »
Personal Finance

Make more, save more, spend smarter, and keep more of what you earn

Business News

Stock market news & analysis

Biotech »

FDA Response to CPI-300’s NDA Anticipated Soon (NASDAQ:IGXT)
02/04/2010 – 9:46 am PST | No Comment

FDA Response to CPI-300’s NDA Anticipated Soon (NASDAQ:IGXT)

CPI-300 is a drug that has been developed by IntelGenx Corp. (NASDAQ:IGXT.OB) and its partner, Cary Pharmaceuticals, Inc, under the Collaborative Agreement signed by the two companies in 2007. The drug is used as an antidepressant with an increased strength and can be used to treat disorders associated with depression. Read the full story »

FDA Response to ODFS’s NDA Anticipated (NYSE:PRX)
02/04/2010 – 9:39 am PST | No Comment
FDA Response to ODFS’s NDA Anticipated (NYSE:PRX)

Strativa Pharmaceuticals is a subsidiary owned by the Par Pharmaceutical Companies, Inc. (NYSE:PRX), a specialty pharmaceutical company that is involved in the development, manufacturing and commercialization of both generic drugs and novel branded drugs.

FDA response on Autologel Sytem Expected Soon (AMEX:GTF)
02/04/2010 – 9:37 am PST | No Comment
FDA response on Autologel Sytem Expected Soon (AMEX:GTF)

On August 7, 2009, Cytomedix, Inc. (NYSE AMEX:GTF) announced that it has submitted to, the United Sates of America’s toughest regulator, the Food and Drug Administration (FDA) a 510(K) for its AutoloGel™ Platelet Separation System. …

FDA response on IL 13-PE expected on February 4, 2010 (NASDAQ:NEOL)
02/04/2010 – 9:30 am PST | One Comment
FDA response on IL 13-PE expected on February 4, 2010 (NASDAQ:NEOL)

On January 4, 2010, NeoPharm, Inc. (NASDAQ:NEOL.PK), a biopharmaceutical company that discovers, develops and markets drugs for treating patients suffering from cancer and other life threatening diseases, disclosed that it has submitted an investigational new …

FDA Response Expected Expected Soon for Bovie (AMEX:BVX)
02/04/2010 – 9:28 am PST | No Comment
FDA Response Expected Expected Soon for Bovie (AMEX:BVX)

On August 3, 2009, Bovie Medical Corporation (AMEX:BVX) announced that it has submitted a 510(K) to the FDA, for its ICON VS electrosurgical generator, in order to obtain pre-market approval. We hope the company will …

Complete Results of Phase 2 trial of Biomoda’s Lung Cancer Test Anticipated (NASDAQ:BMOD)
02/01/2010 – 10:29 am PST | No Comment
Complete Results of Phase 2 trial of Biomoda’s Lung Cancer Test Anticipated (NASDAQ:BMOD)

Biomoda, Inc. (NASDAQ:BMOD.OB), whose headquarter is in Albuquerque, New Mexico, is a company that discovers and develops precise, safe and cheap in-vitro tests that diagnose cancer in the early stage – the period of time …

Article on Perifosone’s Phase 2 trial to be published (NASDAQ:KERX)
02/01/2010 – 10:26 am PST | No Comment
Article on Perifosone’s Phase 2 trial to be published (NASDAQ:KERX)

KRX-0401 (which is more popularly known by its generic name perifosone) is an anti-cancer drug that has been discovered and developed by Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Keryx, which has its headquarters in the New York …

Clinical Trial Results for H1N1 Vaccine Expected Soon (NASDAQ:NVAX)
01/30/2010 – 5:17 pm PST | No Comment
Clinical Trial Results for H1N1 Vaccine Expected Soon (NASDAQ:NVAX)

On December 2, 2009 Novavax, Inc. (NASDAQ:NVAX) announced that it has received encouraging primary data from the first stage of the Phase 2 trial. The trial is being carried out on the company’s newly developed …

FDA’s response on Troponin Assay Anticipated (NASDAQ:NSPH)
01/30/2010 – 5:15 pm PST | One Comment
FDA’s response on Troponin Assay Anticipated (NASDAQ:NSPH)

Nanosphere Inc. (NASDAQ:NSPH) is a pharmaceutical company that develops, manufactures and then brings into market “advanced molecular diagnostics systems” which detect “multiplexed direct genomic and ultra-sensitive protein detection”. All its products are based on the …